NCT07350629 Noninvasive Real-Time Arterial Waveform Monitoring for Cardiovascular Disease Assessment
| NCT ID | NCT07350629 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Anhui Provincial Cancer Hospital |
| Condition | Aortic Regurgitation Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 15 participants |
| Start Date | 2025-12-26 |
| Primary Completion | 2026-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 15 participants in total. It began in 2025-12-26 with a primary completion date of 2026-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to learn whether noninvasive real-time arterial waveform monitoring can be used to assess cardiovascular diseases in adults. The main question it aims to answer is: Can photoacoustic imaging accurately capture arterial waveforms from patients' fingers? Can features extracted from the arterial waveforms reflect the type and severity of cardiovascular diseases? Participants will be asked to place their fingers into the imaging device, where their finger arterial pulse information will be noninvasively recorded.
Eligibility Criteria
Inclusion Criteria: * Age 18-80 years * Able to provide informed consent * For AR group: clinically diagnosed aortic regurgitation * For AS group: clinically diagnosed aortic stenosis * For healthy controls: no history of cardiovascular disease * Able to undergo finger arterial waveform measurement Exclusion Criteria: * History of recent cardiac surgery or intervention (\<6 months) * Hand disorders affecting finger mobility (e.g., arthritis) * Pregnant or breastfeeding women * Participation in other studies affecting arterial waveform * Unable to understand or comply with study procedures
Frequently Asked Questions
Who can join the NCT07350629 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Aortic Regurgitation Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07350629 currently recruiting?
Yes, NCT07350629 is actively recruiting participants. Visit ClinicalTrials.gov or contact Anhui Provincial Cancer Hospital to inquire about joining.
Where is the NCT07350629 trial being conducted?
This trial is being conducted at Hefei, China.
Who is sponsoring the NCT07350629 clinical trial?
NCT07350629 is sponsored by Anhui Provincial Cancer Hospital. The trial plans to enroll 15 participants.